1 Anticancer Drugs Market Overview

• 1.1 Product Overview and Scope of Anticancer Drugs
• 1.2 Anticancer Drugs Segment by Type
  • 1.2.1 Global Anticancer Drugs Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
  • 1.2.3 Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
  • 1.2.4 Hormonal Drugs
• 1.3 Anticancer Drugs Segment by Application
  • 1.3.1 Anticancer Drugs Sales Comparison by Application: (2021-2027)
  • 1.3.2 Lung Cancer
  • 1.3.3 Breast Cancer
  • 1.3.4 Leukemia
  • 1.3.5 Colorectal Cancer
  • 1.3.6 Other
• 1.4 Global Anticancer Drugs Market Size Estimates and Forecasts
  • 1.4.1 Global Anticancer Drugs Revenue 2016-2027
  • 1.4.2 Global Anticancer Drugs Sales 2016-2027
  • 1.4.3 Anticancer Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Anticancer Drugs Market Competition by Manufacturers

• 2.1 Global Anticancer Drugs Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Anticancer Drugs Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Anticancer Drugs Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Anticancer Drugs Manufacturing Sites, Area Served, Product Type
• 2.5 Anticancer Drugs Market Competitive Situation and Trends
  • 2.5.1 Anticancer Drugs Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Anticancer Drugs Players Market Share by Revenue
  • 2.5.3 Global Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Anticancer Drugs Retrospective Market Scenario by Region

• 3.1 Global Anticancer Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Anticancer Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Anticancer Drugs Market Facts & Figures by Country
  • 3.3.1 North America Anticancer Drugs Sales by Country
  • 3.3.2 North America Anticancer Drugs Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Anticancer Drugs Market Facts & Figures by Country
  • 3.4.1 Europe Anticancer Drugs Sales by Country
  • 3.4.2 Europe Anticancer Drugs Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Anticancer Drugs Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Anticancer Drugs Sales by Region
  • 3.5.2 Asia Pacific Anticancer Drugs Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Anticancer Drugs Market Facts & Figures by Country
  • 3.6.1 Latin America Anticancer Drugs Sales by Country
  • 3.6.2 Latin America Anticancer Drugs Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Anticancer Drugs Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Anticancer Drugs Sales by Country
  • 3.7.2 Middle East and Africa Anticancer Drugs Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Anticancer Drugs Historic Market Analysis by Type

• 4.1 Global Anticancer Drugs Sales Market Share by Type (2016-2021)
• 4.2 Global Anticancer Drugs Revenue Market Share by Type (2016-2021)
• 4.3 Global Anticancer Drugs Price by Type (2016-2021)

5 Global Anticancer Drugs Historic Market Analysis by Application

• 5.1 Global Anticancer Drugs Sales Market Share by Application (2016-2021)
• 5.2 Global Anticancer Drugs Revenue Market Share by Application (2016-2021)
• 5.3 Global Anticancer Drugs Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 F. Hoffmann-La Roche Ltd
  • 6.1.1 F. Hoffmann-La Roche Ltd Corporation Information
  • 6.1.2 F. Hoffmann-La Roche Ltd Description and Business Overview
  • 6.1.3 F. Hoffmann-La Roche Ltd Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 F. Hoffmann-La Roche Ltd Product Portfolio
  • 6.1.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
• 6.2 Eli Lilly and Company
  • 6.2.1 Eli Lilly and Company Corporation Information
  • 6.2.2 Eli Lilly and Company Description and Business Overview
  • 6.2.3 Eli Lilly and Company Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Eli Lilly and Company Product Portfolio
  • 6.2.5 Eli Lilly and Company Recent Developments/Updates
• 6.3 CELGENE CORPORATION
  • 6.3.1 CELGENE CORPORATION Corporation Information
  • 6.3.2 CELGENE CORPORATION Description and Business Overview
  • 6.3.3 CELGENE CORPORATION Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 CELGENE CORPORATION Product Portfolio
  • 6.3.5 CELGENE CORPORATION Recent Developments/Updates
• 6.4 Novartis AG
  • 6.4.1 Novartis AG Corporation Information
  • 6.4.2 Novartis AG Description and Business Overview
  • 6.4.3 Novartis AG Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Novartis AG Product Portfolio
  • 6.4.5 Novartis AG Recent Developments/Updates
• 6.5 Pfizer Inc
  • 6.5.1 Pfizer Inc Corporation Information
  • 6.5.2 Pfizer Inc Description and Business Overview
  • 6.5.3 Pfizer Inc Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Pfizer Inc Product Portfolio
  • 6.5.5 Pfizer Inc Recent Developments/Updates
• 6.6 Amgen Inc
  • 6.6.1 Amgen Inc Corporation Information
  • 6.6.2 Amgen Inc Description and Business Overview
  • 6.6.3 Amgen Inc Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Amgen Inc Product Portfolio
  • 6.6.5 Amgen Inc Recent Developments/Updates
• 6.7 Bayer AG
  • 6.6.1 Bayer AG Corporation Information
  • 6.6.2 Bayer AG Description and Business Overview
  • 6.6.3 Bayer AG Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Bayer AG Product Portfolio
  • 6.7.5 Bayer AG Recent Developments/Updates
• 6.8 AstraZeneca
  • 6.8.1 AstraZeneca Corporation Information
  • 6.8.2 AstraZeneca Description and Business Overview
  • 6.8.3 AstraZeneca Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 AstraZeneca Product Portfolio
  • 6.8.5 AstraZeneca Recent Developments/Updates
• 6.9 Takeda Pharmaceutical Company Limited
  • 6.9.1 Takeda Pharmaceutical Company Limited Corporation Information
  • 6.9.2 Takeda Pharmaceutical Company Limited Description and Business Overview
  • 6.9.3 Takeda Pharmaceutical Company Limited Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Takeda Pharmaceutical Company Limited Product Portfolio
  • 6.9.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
• 6.10 Merck & Co.
  • 6.10.1 Merck & Co. Corporation Information
  • 6.10.2 Merck & Co. Description and Business Overview
  • 6.10.3 Merck & Co. Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Merck & Co. Product Portfolio
  • 6.10.5 Merck & Co. Recent Developments/Updates

7 Anticancer Drugs Manufacturing Cost Analysis

• 7.1 Anticancer Drugs Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Anticancer Drugs
• 7.4 Anticancer Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Anticancer Drugs Distributors List
• 8.3 Anticancer Drugs Customers

9 Anticancer Drugs Market Dynamics

• 9.1 Anticancer Drugs Industry Trends
• 9.2 Anticancer Drugs Growth Drivers
• 9.3 Anticancer Drugs Market Challenges
• 9.4 Anticancer Drugs Market Restraints

10 Global Market Forecast

• 10.1 Anticancer Drugs Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Anticancer Drugs by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Anticancer Drugs by Type (2022-2027)
• 10.2 Anticancer Drugs Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Anticancer Drugs by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Anticancer Drugs by Application (2022-2027)
• 10.3 Anticancer Drugs Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Anticancer Drugs by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Anticancer Drugs by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
Hormonal Drugs

Segment by Application
Lung Cancer
Breast Cancer
Leukemia
Colorectal Cancer
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
F. Hoffmann-La Roche Ltd
Eli Lilly and Company
CELGENE CORPORATION
Novartis AG
Pfizer Inc
Amgen Inc
Bayer AG
AstraZeneca
Takeda Pharmaceutical Company Limited
Merck & Co.